Jun 03, 2021 7:30am EDT Mydecine to Participate in the H.C. Wainwright Psychedelics in Psychiatry and Beyond Conference on June 17th
May 25, 2021 7:30am EDT Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms
May 18, 2021 7:30am EDT Mydecine Reports First Quarter 2021 Financial Results and Provides Business Update
May 10, 2021 7:30am EDT Mydecine to Participate in the Benzinga Global Small Cap Conference on May 13th
May 03, 2021 7:30am EDT Mydecine Reports Full Year 2020 Financial Results and Provides Business Update
Apr 07, 2021 7:30am EDT Mydecine Announces Four Lead Novel Drug Candidates and Prepares for Pre-IND Meetings with the FDA and Health Canada To Prepare For Human Clinical